# Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

> **NCT07083765** · PHASE3 · SUSPENDED · sponsor: **Ablative Solutions, Inc.** · enrollment: 142 (estimated)

## Conditions studied

- Hypertension
- Hypertension,Essential

## Interventions

- **DRUG:** Dehydrated Alcohol Injection, USP
- **PROCEDURE:** Sham procedure

## Key facts

- **NCT ID:** NCT07083765
- **Lead sponsor:** Ablative Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2025-09-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-10-31
- **Target enrollment:** 142 (ESTIMATED)
- **Why stopped:** Study enrollment and treatment are temporarily suspended due to an FDA clinical hold. The sponsor is actively addressing the FDA's requests.
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07083765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07083765, "Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07083765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*